Evidence map›Paper›PMID 32648361›Full record

ArticleGenesis (New York, N.Y. : 2000)2020

Generation of transgenic mice that conditionally express microRNA miR-145.

Dwitiya Sawant, Emilie Klevenow, Jeremy T Baeten, Shelby Thomas, Sathiyanarayanan Manivannan, Simon J Conway, Brenda Lilly

Open access · greenAbstract read
In one paragraph

Article in Genesis (New York, N.Y. : 2000), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.2field-weighted citation impact, top 57% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Dwitiya SawantCenter for Cardiovascular Research and The Heart Center, Nationwide Children's Hospital, Columbus, Ohio, USA.
Emilie KlevenowCenter for Cardiovascular Research and The Heart Center, Nationwide Children's Hospital, Columbus, Ohio, USA.
Jeremy T BaetenCenter for Cardiovascular Research and The Heart Center, Nationwide Children's Hospital, Columbus, Ohio, USA.
Shelby ThomasCenter for Cardiovascular Research and The Heart Center, Nationwide Children's Hospital, Columbus, Ohio, USA.
Sathiyanarayanan ManivannanCenter for Cardiovascular Research and The Heart Center, Nationwide Children's Hospital, Columbus, Ohio, USA.
Simon J ConwayHB Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, Indiana, USA.
Brenda LillyCenter for Cardiovascular Research and The Heart Center, Nationwide Children's Hospital, Columbus, Ohio, USA.ORCID 0000-0002-3125-7496
Nationwide Children's Hospital · USIndiana University School of MedicineMarquette University · US

Funding

Training in Congenital and Acquired Heart DiseaseT32HL098039 · NHLBI · RESEARCH INST NATIONWIDE CHILDREN'S HOSP · PI GARG, VIDU, MOHLER, PETER J. · 2009 to 2019
$2.5M
Mechanisms of cardiac and pulmonary fibrosis in relation to TGF-beta signaling and miR-145 functionR01HL135657 · NHLBI · RESEARCH INST NATIONWIDE CHILDREN'S HOSP · PI CONWAY, SIMON JAMES, LILLY, BRENDA J · 2017 to 2020
$1.7M
NHLBI NIH HHS R01 HL135657NHLBI NIH HHS T32 HL098039
6 · The paper itself

Abstract

MicroRNAs are modulators of cellular phenotypes and their functions contribute to development, homeostasis, and disease. miR-145 is a conserved microRNA that has been implicated in regulating an array of phenotypes. These include supporting smooth muscle differentiation, repression of stem cell pluripotency, and inhibition of tumor growth and metastasis. Previously, our lab demonstrated that miR-145 acts to suppress cardiac fibrosis through inhibition of the TGF-β signaling pathway. The range of effects that miR-145 has on different cell types makes it an attractive microRNA for further study. Here we describe the generation of transgenic mice that conditionally express miR-145 through Cre recombinase-mediated activation. Characterization of individual founder lines indicates that overexpression of miR-145 in the developing cardiovascular system has detrimental effects, with three independent miR-145 transgenic lines exhibiting Cre-dependent lethality. Expression analysis demonstrates that the transgene is robustly expressed and our analysis reveals a novel downstream target of miR-145, Tnnt2. The miR-145 transgenic mice represent a valuable tool to understand the role of miR-145 in diverse cell types and to address its potential as a therapeutic mediator for the treatment of disease.

Indexed as

TransgenesAnimalsCell LineGenetic EngineeringIntegrasesMiceMice, Inbred C57BLMicroRNAsMyocytes, CardiacRatsTroponin TCre recombinaseIntegrasesMicroRNAsMIRN145a microRNA, mouseTnnt2 protein, mouseTroponin TcardiovascularmiR-145smooth muscletransgenic mice

Identifiers

PMID32648361
PMCPMC7672654
OpenAlexW3042156208

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.